MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
CERS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cerus (CERS) Ownership - Who owns Cerus?

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Medical Specialties
Address
1220 Concord Avenue
Phone
+1 925 288-6000
Employees
288
Web
https://www.cerus.com

Details

Group
Domestic Stock Funds
Category
Health Services
Capitalization
252.08M
P/E Ratio
N/A
Total Cash
78.03M
Projected Growth
N/A
Total Debt
98.9M
Revenue
192.51M
Risk (Beta)
2.14
Dividend Yield
N/A
Total Cash/Share
0.41
Total Debt/Equity
7.28
Revenue/Share
1.03 USD as % of share price

Fundamentals

CERS
Capitalization
252M
P/E Ratio
N/A
Risk (Beta)
2.14
Dividend Yield
N/A
Total Cash
78M
Total Cash/Share
0.41
Total Debt
98.9M
Total Debt/Equity
7.28
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.03%
Revenue
193M
ROE
N/A
Book Value
55.4M
P/B Ratio
4.55
Cash Flow
N/A
Earnings
-0.1
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
191K
Current Ratio
2.00
Current Revenue Per Employee
186637.02
Dividends Per Share - Security
N/A
EBITDA
-8.62M
Float
N/A
Float - Current
N/A
Gross Income Margin
55.25
Revenue To Assets
-9.47
Shares Held By Institutions
607M
Shares Outstanding - Current
192M
Total Liabilities
157M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-14.935
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CERS
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For CERS
(Try 14 days for Free)
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CERS showed earnings on August 05, 2025. You can read more about the earnings report here.
View AI-Driven Trading
A.I. Advisor
published General Information

General Information

a developer of the INTERCEPT Blood System for platelets and plasma

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1220 Concord Avenue
Phone
+1 925 288-6000
Employees
288
Web
https://www.cerus.com